Does OBINUTUZUMAB Cause Neutrophil count decreased? 246 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 246 reports of Neutrophil count decreased have been filed in association with OBINUTUZUMAB (Gazyva). This represents 1.7% of all adverse event reports for OBINUTUZUMAB.
246
Reports of Neutrophil count decreased with OBINUTUZUMAB
1.7%
of all OBINUTUZUMAB reports
25
Deaths
91
Hospitalizations
How Dangerous Is Neutrophil count decreased From OBINUTUZUMAB?
Of the 246 reports, 25 (10.2%) resulted in death, 91 (37.0%) required hospitalization, and 9 (3.7%) were considered life-threatening.
Is Neutrophil count decreased Listed in the Official Label?
Yes, Neutrophil count decreased is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Neutrophil count decreased?
CLOZAPINE (2,523)
LENALIDOMIDE (2,471)
PALBOCICLIB (2,224)
CYCLOPHOSPHAMIDE (1,985)
CARBOPLATIN (1,734)
PACLITAXEL (1,562)
RITUXIMAB (1,509)
DEXAMETHASONE (1,320)
BEVACIZUMAB (1,225)
POMALIDOMIDE (1,062)
Which OBINUTUZUMAB Alternatives Have Lower Neutrophil count decreased Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE